Agios Pharmaceuticals, Inc.

Q4 2018 13F Holders

Symbol
AGIO
CUSIP
00847X104
Type
Equity
Class
COM
Num filings
217
Total reported value, excl. options
$2.68 B
Manager Report Date Value ($000) Shares Option Type